Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease

BACKGROUND: There is a clinical need to develop biomarkers of small bowel damage in coeliac disease and Crohn’s disease. This study evaluated intestinal fatty acid binding protein (iFABP), a potential biomarker of small bowel damage, in children with coeliac disease and Crohn’s disease. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Logan, Michael, MacKinder, Mary, Clark, Clare Martha, Kountouri, Aikaterini, Jere, Mwansa, Ijaz, Umer Zeeshan, Hansen, Richard, McGrogan, Paraic, Russell, Richard K., Gerasimidis, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125891/
https://www.ncbi.nlm.nih.gov/pubmed/35606704
http://dx.doi.org/10.1186/s12876-022-02334-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125891/
https://www.ncbi.nlm.nih.gov/pubmed/35606704
http://dx.doi.org/10.1186/s12876-022-02334-6

Ejemplares similares